Skip to content

Beyond Meat BYND Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Wells Fargo & Company logo
Wells Fargo & CompanyWFC
$9B0.0%
Carrier Global logo
Carrier GlobalCARR
4B0.0%
eBay logo
eBayEBAY
3.6B0.0%
Duke Energy logo
Duke EnergyDUK
2B0.0%
3M logo
3MMMM
3B
U.S. Bancorp logo
U.S. BancorpUSB
4B0.0%

Other financials

Income statement

See full
Revenue$58.2M-15.3%
Gross profit$2.0M+129%
Operating income-$41.1M+36.1%
Net income-$28.5M+53.4%
EPS (diluted)-$0.06+92.5%

Balance sheet

See full
Cash & equivalents$205.8M+77.6%
Total debt$526.7M-56.9%
Total equity-$21.1M+96.8%
Total assets$579.5M-10.0%

Cash flow

See full
Operating cash flow-$5.0M+80.8%
CapEx$2.5M-43.7%
Free cash flow-$7.6M+75.3%

Valuation

See full
Market cap$352.65M+34.4%
Enterprise value$673.58M-50.8%
P/E1.5×
P/S1.3×+0.5×

Profitability

See full
Gross margin6.5%+3.8pp
Operating margin-120.2%-521pp
Net margin91.9%+67.4pp
FCF margin-50.6%+51.8pp

Returns & leverage

See full
Return on equity-167.4%
Debt / equity28.2×
Current ratio2.9×-0.5×

Where this comes from

Reported directly by Beyond Meat in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Beyond Meat’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beyond Meat's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beyond Meat's common stock, shares authorized (in shares)?
Beyond Meat (BYND) reported common stock, shares authorized (in shares) of $3B in Q1 2026.
How has Beyond Meat's common stock, shares authorized (in shares) changed year-over-year?
Beyond Meat's common stock, shares authorized (in shares) increased by 500.0% year-over-year, from $500M to $3B.
What is the long-term trend for Beyond Meat's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Beyond Meat's common stock, shares authorized (in shares) has grown at a 43.1% compound annual growth rate (CAGR), from $500M to $3B.